Are You Looking For Medical Devices Certifications?
Get it here!Looking for Regulatory Consultant ?
Manufacturers seeking to place a medical device on the EU market must prepare and maintain technical documentation that demonstrates compliance with Regulation (EU) 2017/745 (MDR). This documentation serves as clear evidence that the product fulfills all relevant safety, performance, and regulatory requirements in accordance with the EU MDR.
Comprehensive technical documentation plays a critical role in ensuring transparency, traceability, and an efficient CE marking process. It allows regulatory authorities and notified bodies to evaluate product compliance more effectively while supporting smoother access to the European Union market.
Technical documentation under Regulation (EU) 2017/745 is the regulatory file that every medical device manufacturer must prepare and maintain to demonstrate that their device meets all applicable MDR requirements. It is the cornerstone of the conformity assessment process and the primary reference used by Notified Bodies and competent authorities when evaluating a device for CE marking and market access.
All technical documentation, regardless of device type or risk class, must be presented in a clear, organised, and readily searchable format. Notified Bodies expect documentation that is structured logically, with information that is unambiguous and easy to navigate during assessment.

At Maven Profcon Services LLP, we provide end-to-end support in MDR technical documentation preparation. Our services include preparation of a complete technical file, gap assessment of existing documentation and its restructuring in accordance with Annex II and Annex III, compilation of clinical evaluation and risk management files for demonstrating compliance. Our goal is to ensure every organisation/manufacturer we support has a technical file that is thorough, well-structured, and ready for Notified Body review.
MDR Technical Files includes:
1. Device Description And Specification, Including Variants And Accessories: This section presents a comprehensive description of the device, including its intended purpose, operating principles, and classification. It further describes device variants, configurations, and related accessories. Information on materials, components, and key functional characteristics assists regulators in obtaining a thorough understanding of the product.
2. Information To Be Supplied By The Manufacturer: This section covers all information provided by the manufacturer, including Instructions for Use (IFU), packaging labels, and promotional materials. All content must be accurate, consistent, and aligned with MDR requirements to support the safe and effective use of the device.
3. Design and Manufacturing Information: A detailed description of the device’s design and manufacturing process is documented here. The goal is to establish evidence from initial development till final production across all involved sites, including suppliers and subcontractors.
4. General Safety and Performance Requirements: General Safety and Performance Requirements under Annex I of Regulation (EU) 2017/745 define the baseline safety and performance standards every medical device must meet. This section documents conformity against each applicable requirement, supported by references to harmonised standards, Common Specifications (CS), or other accepted methods. It also includes a clear justification for any requirements considered non-applicable. The aim is to provide a clear and traceable correlation between the applicable regulatory requirements and the supporting evidence documented within the technical file.
5. Benefit-Risk Analysis and Risk Management: Every medical device carries an inherent level of risk. This section demonstrates that those risks have been systematically identified, evaluated, and controlled, and that the overall benefits of the device outweigh them. It should include a comprehensive benefit-risk analysis in accordance with the relevant sections of Annex I, demonstrating why the device is considered safe and effective for its intended purpose. It documents the risk management process followed, the measures implemented to reduce or eliminate risks, and the outcomes of those measures. The primary goal of this section is to provide a transparent account of how safety has been built into the device.
6. Product Verification and Validation: This section presents the results and critical analysis of all verification and validation activities undertaken to confirm that the device meets the applicable requirements of Regulation (EU) 2017/745. It encompasses pre-clinical and clinical data, the Clinical Evaluation Plan, Clinical Evaluation Report, and where applicable the Post-Market Clinical Follow-up Plan and Report.
Stability data covering shelf life, transport stability is included where applicable, alongside software verification and validation documentation and any additional evidence required for specific device types or intended uses.
7. Post-Market Surveillance: Post-market surveillance documentation captures how a manufacturer monitors, evaluates, and responds to real-world device performance after market entry. It includes a structured surveillance plan, periodic reporting on safety and performance findings, assessment of emerging risks, and documentation of any corrective actions taken to maintain the device’s benefit-risk acceptability throughout its lifetime. It also covers the preparation of Periodic Safety Update Reports (PSUR) depending on the class of the device, Post-market Surveillance Reports to summarise post-market findings. Collectively, these activities help identify potential issues at an early stage and facilitate timely corrective actions, thereby ensuring continued compliance and patient safety.
8. Administrative Information: This section forms the organisational backbone of the technical file. It brings together manufacturer details, Authorised Representative information where applicable, relevant certificates, Declaration of Conformity, and any legal documentation required to establish and maintain the regulatory status of the device throughout its lifecycle.
Getting MDR technical documentation right is what separates manufacturers who achieve timely CE certification from those who face repeated Notified Body queries and delays. At Maven Profcon Services LLP, we ensure that manufacturers are firmly in the first category by:
For further information on MDR Technical Documentation, refer to the following document:
Yes. A CE marking technical file is required before placing a medical device on the EU market.
Manufacturers must retain documentation for 10 years, or 15 years for implantable devices.
The manufacturer is legally responsible, though many companies work with regulatory experts for structured preparation.
The regulatory requirements for preparing and maintaining Technical Documentation for medical devices are defined in Annex II and Annex III of the European Union Medical Device Regulation (MDR) (EU) 2017/745. These annexes specify the structure, content, and post-market documentation expected for demonstrating compliance with the MDR.
For practical interpretation and industry best practices, manufacturers can also refer to the “Team-NB Position Paper” – Best Practice Guidance for the Submission of Technical Documentation under Annex II and III of Medical Device Regulation (EU) 2017/745.” This guidance document provides recommendations on how to organize and present Technical Documentation to the Notified Bodies.
Manufacturers can find the list of designated Notified Bodies for MDR (EU) 2017/745 in the NANDO (New Approach Notified and Designated Organisations) database managed by the European Commission.
The database provides information on:
Access the database here: Notified bodies (NANDO)